CHOLECALCIFEROL
Cholecalciferol, also known as vitamin D3, is a molecule that is synthesized or of animal origin. It is used in skincare formulations.
Roles & functions
Skin conditioning — Keeps the skin in good condition and protects it; improves its comfort.
Safety limit not to exceed
| Population | Limit / day | Type of reference | Source |
|---|---|---|---|
| Adult · general population | 100 µg | Tolerable Upper Intake Level (UL) | EFSA NDA 2023 (EFSA J 21(8):8145) |
| Pregnancy | 100 µg | Tolerable Upper Intake Level (UL) | EFSA NDA 2023 (EFSA J 21(8):8145) |
| Breastfeeding | 100 µg | Tolerable Upper Intake Level (UL) | EFSA NDA 2023 (EFSA J 21(8):8145) |
| From 12 months to 131 months | 50 µg | Tolerable Upper Intake Level (UL) | EFSA NDA 2023 (EFSA J 21(8):8145) |
| From 11 years to 215 months | 100 µg | Tolerable Upper Intake Level (UL) | EFSA NDA 2023 (EFSA J 21(8):8145) |
| From 0 months to 6 months | 25 µg | Tolerable Upper Intake Level (UL) | EFSA NDA 2023 (EFSA J 21(8):8145) |
| From 7 months to 11 months | 35 µg | Tolerable Upper Intake Level (UL) | EFSA NDA 2023 (EFSA J 21(8):8145) |
Official reference limit, for information only, this is not personalised advice. Ask a pharmacist about your situation.
Last verified :
What the authorities say
| Authority | Status |
|---|---|
| Commission européenne (CosIng, Règl. 1223/2009) | Interdit (Annexe II) — Ergocalciferol (INN) and Cholecalciferol (vitamins D2 and D3) |
| Endocrine Disruptor Lists (EU authorities, edlists.org) — maj Thu, 01 Oct 2026 04:00:13 GMT | Perturbateur endocrinien — confirmé |
| Endocrine Disruptor Lists (EU authorities, edlists.org) — maj Thu, 01 Oct 2026 04:00:13 GMT | Risque environnemental — confirmé |
| CLP classification (Reg. 1272/2008) | No CMR classification |
| ECHA — Candidate List (SVHC, REACH Art. 59) | Not on the Candidate List (SVHC) |
| European Commission (Reg. 1223/2009, Annex III) | No cosmetic allergen subject to mandatory labelling |
| European Commission (EU catalogue of nanomaterials, Reg. 1223/2009) | No referenced nanoform |
| European Commission — Annex II (Reg. 1223/2009) — maj Thu, 01 Oct 2026 05:00:28 GMT | Prohibited in cosmetics (Annex II) — Ergocalciferol (INN) and Cholecalciferol (vitamins D2 and D3) — Annexe II, entrée 335 |
Last verified :
What the EFSA says
Yes. Vitamin D helps to reduce the risk of falling associated with postural instability and muscle weakness. Falling is a risk factor for bone fractures among men and women 60 years of age and older. The claim may be used only for food supplements which provide at least 15 μg of vitamin D per daily portion. Information shall be given to the consumer that the beneficial effect is obtained with a daily intake of 20 μg of vitamin D from all sources. For food supplements with added vitamin D the claim may be used only for those targeting men and women 60 years and older
Yes. Vitamin D contributes to normal blood calcium levels
Yes. Vitamin D contributes to the maintenance of normal bones
Yes. Vitamin D is needed for normal growth and development of bone in children
Yes. Vitamin D contributes to the maintenance of normal muscle function
Yes. Vitamin D contributes to normal absorption/utilisation of calcium and phosphorus
Yes. Vitamin D has a role in the process of cell division
Yes. Vitamin D contributes to the maintenance of normal teeth
Yes. Vitamin D contributes to the normal function of the immune system
Yes. Vitamin D contributes to the normal function of the immune system in children.
Source: EFSA / Reg. (EU) 432/2012
Who it is not recommended for
Chez l'enfant, les autorités recommandent de privilégier la vitamine D sous forme de médicament, de vérifier la dose par goutte et de ne pas cumuler plusieurs produits qui en contiennent. Demandez conseil à votre pharmacien.
A question about this ingredient?
Lou answers you and looks at your products with you, in store.